A method for the accurate quantitation of mitral regurgitation in man was Gescribed and tested in 23 patients. The technique involves a constant infusion of xenon-133 into the left ventricle for 2 minutes. Left atrial and arterial samples must be withdrawn after constant concentration is achieved and before recirculation reaches high values. It was shown that concentration of indicator at both sample sites was constant by 60 seconds from the onset of infusion and that at 60 and 120 seconds left atrial concentration would rise on the average to 2.3 and 4.3% arterial concentration, respectively, as a result of recirculation. It could be demonstrated by altering the left atrial sample site that error due to incomplete mixing in the left atrium might average 2% and would be unlikely to exceed 7%. Values for cardiac output and regurgitant flow and regurgitant fraction, measured between 60 and 120 seconds, were relatively constant in any one patient. Regurgitant fraction varied from 1 to 84% of blood leaving the left ventricle in systole in different patients and there was good correlation with clinical and angiocardiographic estimates of severity of regurgitation.
1 HERE IS as yet no accurate method for the measurement of regurgitant flow in mitral valve disease. The quantity of indicator reaching the left atrium after an instantaneous injection into the left ventricle will be related to the volume of regurgitation." 2 However, accurate quantitation of regurgitant flow by this method is subject to two potential sources of error. Unless blood and indicator are well mixed in the left ventricle, the quantity of indicator passing to the left atrium will not Supported by grants from the John A. Hartford Foundation, Inc., and the Medical Research Council of Canada (MT-1241).
This study was reported at the Fifty-eighth Annual
Meeting of the American Society for Clinical Investigation in Atlantic City, May 2, 1966. Circulation, Volume XXXV, March 1967 Infusion of krypton Ventilation perfusion ratios accurately reflect the volume of regurgitant blood flow. However, there is good evidence that so long as injections are not made in the immediate vicinity of the mitral valve, this source of error can be ignored. 3 In addition, the sample of left atrial blood must reflect the mean concentration of indicator in blood leaving the left atrium.' Unfortunately, the left atrial concentration, which is observed after a bolus injection of indicator into the left ventricle, is reported to be highly dependent on the exact site in the left atrium from which samples are withdrawn. 2 3 Thus, incomplete mixing of blood in the left atrial chamber prevents the confident quantitation of mitral regurgitation by application of this method. Error from this source could not only be reduced in magnitude, but could be accurately estimated if the instantaneous injection of indicator were replaced by a constant infusion, with continuous sampling from left atrium and systemic artery. In the absence of recirculation, the concentrations at both these sites would rise to plateau at constant values. At this time, arterial concentration would depend only on the cardiac output, while left atrial concentration would depend both on the regurgitant flow and the cardiac output. Cardiac output and regurgitant flow could therefore be derived from analysis of left atrial and systemic arterial blood drawn at this time. Furthermore, it would be possible to estimate the magnitude of differences in concentration of indicator at different sites in the left atrium due to incomplete mixing, by withdrawing samples from different sites in the left atrial chamber while the constant infusion was continued.
The feasibility and accuracy of such an approach were tested in the present study by the constant infusion and continuous sam-pling technique with xenon-133 as an indicator. The radioactivity of this gas is easily measured and because of its low partition coefficient, recirculating gas dissolved in pulmonary arterial blood is largely cleared in t-he lungs so that recirculation to the left atrium is minimal.
Methods
Twenty-three patients with heart disease were studied in the course of routine cardiac catheterization (table 1) . Rheumatic mitral regurgitation alone or in combination with other valve defects was present in 19 subjects as judged by clinical catheterization and angiocardiographic studies. In two subjects with secundum-type atrial septal defect, in one with aortic valve disease, and in one with aortic valve disease and mitral stenosis there was no evidence of mitral regurgitation. In the course of routine left heart catheterization, catheters were passed via the left brachial artery into the left ventricular cavity and into the left atrium from the 
"Diagnosis" reflects principal lesions; associated minor lesions are in parentheses. Cine-angio = assessment of degree of mitral regurgitation by cineangiography. MS mitral stenosis. AS aortic stenosis. MI = mitral incompetence. TI = tricuspid incompetence. AI aortic incompetence. ASD = atrial septal defect. NSR normal sinus rhythm. AF = atrial fibrillation. CHB complete heart block. CAD = coronary artery disease. A solution of xenon-133 in sterile normnal saline (0.07 to 0.144 mc/ml) was infused into the left ventricle at a constant rate of 9.89 ml/min for approximately 3 minutes. At the same time, blood was withdrawn from a systemic artery and from either the pulmonary vein or left atrium at a rate of 15.3 ml/min through sampling systems of known volume by constant withdrawal pumps. The blood samples passed continuously through helical glass cuvettes fixed in close apposition to the surface of fl2-inch sodium iodide crystal-scintillation detectors while the output of each was recorded by a Picker "Dual Rate Computer" (no. 606-145) set to count at 0.5second intervals. Count rate was recorded on a direct-writing oscillograph (Sanborn Co., Waltham, Mass., no. 150,15) at a paper speed of 1 mm/sec. The first change of radioactivity at the catheter or needle tip was detected by this system in 6 and 3 seconds, respectively, and 90% of full activity was reached in a further 13 and 9.5 seconds. The procedure was estimated to result in a total body dose of radiation of less than 30 m rad and a lung dose of less than 50 m rad.
In the absence of recirculation, under steadystate conditions, cardiac output (Q, L/min) can be determined from arterial concentration of indicator (CA, counts/ml) and the rate of infusion of indicator (I, counts/min).
I
Thus: Q = CA (1) The forward flow of blood across the mitral valve in ventricular diastole (QLV. L/min) is made up of the pulmonary venous flow from the lungs (Q) and the regurgitant flow ( QR, L/min).
Thus: QLV= Q+ QR (2) Furthermore, when the concentration of indicator in peripheral artery (CA) and left atrium (CLA) are constant, all the indicator that enters the left atrium must leave it.
Thus: QLV XCLA = QR X CA (3) (Assuming CA = CLV) Substituting (2) in (3):
(0 + 0R) CLA = QR X CA or CLA (4) CA CLA X Q Circulation, Volume XXXV, March 1967 The regurgitant fraction (RFr), which is the ratio of regurgitant flow to the sum of regurgitant plus forward flow, is proportional to the ratio of concentration of indicator in left atrium to the concentration in left ventricle.2
Thlus: RFr = CLA/CA (5) 
Results
A typical time-concentration curve from a patient with mitral regurgitation can be seen in fig. la . After the first appearance of indicator in arterial blood (To) concentration rises rapidly in both arterial and left atrial blood to reach "constant" values, which then increase slowly over the subsequent 3 minutes due to recirculation of xenon. The extent of recirculation can be seen by observing the rate of increase of xenon in pulmonary venous blood in another patient with pure mitral stenosis ( fig. lb ).
Valid measurements of cardiac output and regurgitant flow could only be derived from arterial and left atrial concentration after a steady state had been reached and before The concentration of xenon (a) in brachial arterial (BA) and left atrial (LA) blood resulting from a constant infusion of xenon into the left ventricle in a patient with mitral regurgitation. Time is corrected for the transit time of indicator in the sampling system. A= time at which "steady-state" values are reached. X = time at which sampling site in left atrium is altered by partial withdrawal of catheter. the occurrence of significant recirculation. The times were recorded at which the rising concentration of indicator at each sample site reached an asymptote with the subsequent plateau values (see "A", fig. 1 ). In arterial blood this took place in all subjects from 15 to 55 seconds after T. In 19 patients with mitral regurgitation left atrial concentration became "constant" between 20 and 58 seconds. Thus the earliest time at which samples could be accepted as representing steady values at both sites was arbitrarily set at 60 seconds.
The time of onset and the extent of recirculation could be assessed in seven patients. In three patients without mitral regurgitation and in four instances in which blood was sampled from a pulmonary vein, it was possible to observe the increase of radioactivity in pulmonary venous blood as the infusion continued for a period of approximately 3 minutes. An example of such a study is shown in figure lb. Xenon was first detected in pulmonary venous blood at an average time of 29 seconds. The average concentration at 60 seconds, as a per cent of arterial concentration, was 2.3% (range 1 to 3.8%) and by 120 seconds this had risen to 4.3% (range 2.4 to 9.4%) (table 3) . It is clear from the above observations that cardiac output could be measured with some confidence from the arterial concentration at 60 seconds, as steady-state values were established in all cases by this time. Furthermore, as judged by the pulmonary venous concentration of indicator, the error due to recirculation at 60 seconds was small.
Cardiac output was accordingly estimated at 60 seconds. Next, by scrutiny of each record, the highest and lowest values for arterial concentration between 60 and 120 seconds were ascertained, and from these values the highest and the lowest possible values for cardiac output were computed (tables 2 and 3). In spite of the fact that error due to increasing recirculation of indicator was ignored, deviation from the 60-second value was minimal in most studies and exceeded 10% of the 60second value in only four instances.
Regurgitant flow was also calculated at 60 seconds (table 2) . There was reasonable correlation between these values and the impression gained from clinical, angiocardiographic (table 1), and surgical evidence. As with cardiac output, estimation was then made of the greatest variation in regurgitant flow from the 60-second value which could be computed from the arterial and left atrial concentrations between 60 and 120 seconds. These values (table 2) thus represent both the true variation of QR as well as the sum of all errors, including error due to recirculation. In spite of this, the greatest deviation from the 60-second value exceeded 10% of the 60second value in only four instances.
Regurgitant fraction is less influenced by recirculation, which affects both numerator and denominator of the calculation. The greatest deviation from the 60-second value exceeded 10% of the 60-second value in only two instances ( fig. 2, table 2 ).
Incomplete mixing within the left atrium was sometimes present even during the steady state and the extent of inhomogeneity could be assessed in 12 studies (table 2) . At approximately 130 seconds after the onset of infusion the left atrial catheter was withdrawn 5 to 8 cm while observations were continued. The relationship between regurgitant fraction at 60 seconds and the highest and lowest values that could be computed for regurgitant fraction (joined by a vertical bar) between 60 and 120 seconds. Lines denote identity ±10%. This change of sampling site within the left atrium caused no detectable change in concentration in six patients. The average change was 2.2% (range 0 to 7%) of arterial concentration causing changes in the calculated regurgitant fraction of the identical magnitude ( fig. 3 ).
Discussion
There have been several attempts in the past to quantitate mitral regurgitation by indicator-dilution techniques. Following a bolus injection of indicator into the pulmonary artery or left ventricle there is distortion of the downstream indicator-dilution curve, which is related to the severity of regurgitation. However, it is not possible to distinguish between the effects of regurgitation itself and the volume of distribution of dye, and several ingenious attempts to make use of this type of measurement have not been widely applied.4-6 An alternative approach, the comparison of upstream (LA) and downstream (arterial) curves, following a bolus injection into the left ventricle, is not subject to this error.2' 3However, although it has been shown that the influence of incomplete mixing of indicator in the left ventricle is negligible so long as indicator is not injected immediately below the mitral valve, the influence of incomplete mixing in the left atrium after a bolus injection may be considerable. 3 During a continuous infusion of indicator into the left ventricle, however, differences The relationship between left atrial concentration as a percentage of arterial concentration (that is, regurgitant fraction) before and after movement of the left atrial sampling site. Lines denote identity + 10%.
of concentration of indicator within the left atrium will be less than following a bolus injection. In the first beat after a bolus injection, left ventricular concentration is maximal and falls exponentially, while mean left atrial concentration is low, rises over the next few beats, and then falls again.' Thus the difference between the concentration within the regurgitant jet of blood from the left ventricle and more remote parts of the left atrium is large during the initial portion of the curve, and the concentration of an atrial sample may vary greatly with the position of the left atrial catheter. By contrast, during constant infusion, true mean left atrial concentration rises with left ventricular concentration, and the differences between concentration in the regurgitant jet and more remote sites in the left atrium are accordingly less. In addition, the degree of inhomogeneity of left atrial content during steady state can readily be tested by sampling from various sites in the atrial chamber. As reported above, the differences in left atrial concentration that resulted from moving the catheter tip were small and were equivalent to an average difference of regurgitant fraction of 2.2% (range 0 to 7%).
In view of these findings it is surprising that Arditi and associates 7 found that a technique comparable to ours gave an extremely poor index of "mitral regurgitation" in an animal preparation. Those authors employed dogs in which there was a bypass from the apex of the left ventricle to the left atrium and attempted to measure bypass flow by continuous infusion of Evans blue dye into the left ventricle with continuous arterial and left atrial sampling. The reason for their failure lies almost certainly in the design of their model. Validity of the method is completely dependent on mixing of indicator in the left ventricle and mixing of the shunted blood with the left atrial content. To-and-fro movement of blood between ventricle and atrium, as occurs in the presence of mitral regurgitation, must greatly facilitate mixing. Blood shunted through a bypass from left ventricular apex to left atrium would not be so likely to promote mixing in either chamber, and the amount of indicator passing to the aorta or to the shunt must be greatly influenced by the exact site of the injection into the left ventricular cavity.
Before the continuous-infusion technique, described here, could be routinely applied, it was necessary to determine the earliest time after onset of infusion at which arterial and left atrial concentrations became constant.
Before this time no meaningful values could be obtained. The longer the sampling was delayed, thereafter, the greater would be error Circulation, Volume XXXV, March 1967 due to recirculation. With appropriate correction for phase-lag introduced by our sampling system, we found that indicator first appeared in arterial blood 0 to 3 seconds after the onset of infusion and that a constant value was reached in all studies before 60 seconds. We thus concluded that samples could be safely withdrawn from an artery at any time after 60 seconds. A steady state had also been established in the left atrium by this time. The time taken to reach a constant concentration in the left atrium is determined by three factors, the input of indicator-free blood from pulmonary veins, the regurgitant flow, and the left atrial volume. The first two values having been estimated from the equilibrium concentrations, as described above, left atrial volume could also have been calculated from the rate with which equilibrium values were reached if the time constant of the sampling system were greatly reduced. This could be achieved by increasing the speed of withdrawal of samples.
It was also necessary to establish the time of onset and the extent of recirculation of indicator in pulmonary venous blood. The rate of rise of indicator in pulmonary venous blood depends on several factors, which include the arterial concentration, the rate of rise in systemic venous blood, the partition coefficient of xenon, and the ventilation perfusion ratios existing throughout the lung. While arterial and systemic venous concentration can be measured and partition coefficient is constant, the ventilation perfusion ratios in the lung constitute the greatest single unknown variable. In the presence of large anatomical or functional intrapulmonary shunts, error due to recirculation will increase. In patients such as those studied here, however, it would appear that error due to recirculation is negligible at 60 seconds and is acceptably small at any time between 60 and 120 seconds, and if sampling is confined to this time period, recirculation can reasonably be ignored. This seems preferable to the method described by Lynborg and associates8 which involves a 12-minute infusion of krypton and calculation of the likely pulmonary venous concentration during this time from the relative concentration in pulmonary artery and left atrium observed during washout of krypton from the body.
Our results indicate that the continuousinjection technique with xenon-133 in patients with mitral regurgitation offers a reasonably accurate method of measuring regurgitant flow, with only a small addition to the routine catheterization technique. Withdrawal of continuous samples from the left atrium and systemic artery would not, of course, be necessary for routine quantitation of mitral regurgitation. Cardiac output and regurgitant flow could most simply be determined by the simultaneous withdrawal of "spot"' samples from a systemic artery and left atrium over fairly short periods of time. In the presence of ventricular irregularity, however, regurgitant fraction may vary from beat to beat and an average value for several beats will have greater clinical significance than would a value based on observation for a very short time period. For this reason, when "spot" sampling is used, instead of continuous withdrawal, samples would be withdrawn over a period of at least 10 to 15 seconds.
